+91 6376341881
SoMex Research & Health Organization
Clinical Research Organization

Latest News



Head & Neck Squamous Cell Carcinoma.


CBKM120H2201- Phase II multicenter randomized, double blind, placebo controlled study assessing the efficacy of buparlisib (BKM120) plus paclitaxel vs. placebo plus paclitaxel in patients with platinum pre-treated recurrent or metastatic head and neck squamous cell carcinoma.




Other Latest News


SoMex Research & Health Organization

Get in Touch

+91-141-2504996
somexresearch@gmail.com
www.somexresearch.com

About

Services